Trial · NCT00837577
Adverse events36
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 36
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Sitagliptin/Sitagliptin (Data Through Week 12) | 5 | 70 | 6 |
| other | Nasopharyngitis | Infections and infestations | Placebo/Sitagliptin (Data Through Week 12) | 4 | 63 | 4 |
| other | Nasopharyngitis | Infections and infestations | Pooled Sitagliptin (Data Through Week 52) | 40 | 133 | 66 |
| other | Blood Triglycerides Increased | Investigations | Sitagliptin/Sitagliptin (Data Through Week 12) | 1 | 70 | 1 |
| other | Blood Triglycerides Increased | Investigations | Placebo/Sitagliptin (Data Through Week 12) | 0 | 63 | 0 |
| other | Blood Triglycerides Increased | Investigations | Pooled Sitagliptin (Data Through Week 52) | 8 | 133 | 9 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Sitagliptin/Sitagliptin (Data Through Week 12) | 1 | 70 | 1 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Placebo/Sitagliptin (Data Through Week 12) | 1 | 63 | 1 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Pooled Sitagliptin (Data Through Week 52) | 8 | 133 | 10 |
| serious | Cataract | Eye disorders | Sitagliptin/Sitagliptin (Data Through Week 12) | 0 | 70 | 0 |
| serious | Cataract | Eye disorders | Placebo/Sitagliptin (Data Through Week 12) | 0 | 63 | 0 |
| serious | Cataract | Eye disorders | Pooled Sitagliptin (Data Through Week 52) | 1 | 133 | 2 |
| serious | Glaucoma | Eye disorders | Sitagliptin/Sitagliptin (Data Through Week 12) | 0 | 70 | 0 |
| serious | Glaucoma | Eye disorders | Placebo/Sitagliptin (Data Through Week 12) | 0 | 63 | 0 |
| serious | Glaucoma | Eye disorders | Pooled Sitagliptin (Data Through Week 52) | 1 | 133 | 2 |
| serious | Anal Stenosis | Gastrointestinal disorders | Sitagliptin/Sitagliptin (Data Through Week 12) | 0 | 70 | 0 |
| serious | Anal Stenosis | Gastrointestinal disorders | Placebo/Sitagliptin (Data Through Week 12) | 0 | 63 | 0 |
| serious | Anal Stenosis | Gastrointestinal disorders | Pooled Sitagliptin (Data Through Week 52) | 1 | 133 | 1 |
| serious | Gastric Ulcer | Gastrointestinal disorders | Sitagliptin/Sitagliptin (Data Through Week 12) | 0 | 70 | 0 |
| serious | Gastric Ulcer | Gastrointestinal disorders | Placebo/Sitagliptin (Data Through Week 12) | 0 | 63 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00837577/events